Christina Grace Anton Naveen Kumar , Hepshiba Selvan , Shakthi Sri Sahithya Kumar , Thirunavukkarasu Palaniyandi , Gomathy Baskar , Hemapreethi Surendran , Mohd Saeed , Safia Obaidur Rab
{"title":"Key genes in the Hippo-YAP pathway: Implications for cervical cancer","authors":"Christina Grace Anton Naveen Kumar , Hepshiba Selvan , Shakthi Sri Sahithya Kumar , Thirunavukkarasu Palaniyandi , Gomathy Baskar , Hemapreethi Surendran , Mohd Saeed , Safia Obaidur Rab","doi":"10.1016/j.genrep.2025.102272","DOIUrl":null,"url":null,"abstract":"<div><div>One of the leading causes of cancer-related deaths globally is cervical cancer, which has many molecular mechanisms associated with its pathophysiology, including the dysfunction of the Hippo-YAP signalling system. The route can affect important biological processes such as cell growth, division, and survival. Risk factors for cervical cancer include long-term use of oral contraceptives, early sexual activity, multiple sexual partners, human papillomavirus infection, and cervical intraepithelial neoplasia. The disease mechanisms are regulated by many genes such as EGFR, MYC, CCND1, and ERBB2. The Hippo signalling pathway phosphorylates YAP/TAZ, thereby inhibiting carcinogenic potential. Dysregulation of the pathway has been linked with poor prognosis, lymph node metastasis, and cervical carcinoma in the early stage through YAP/TAZ activation. Progress in sequencing technologies, such as transcriptomics, single-cell genomic profiling, and multi-omics integration, has also shed light on this pathway for setting the foundation for better treatment. Vaccination against HPVs with high rates and intensive screening programs are critical for reducing cervical cancer incidence and death reduction. This review analyzed cervical cancer pathogenic genes and gene expression profiles by the Hippo-YAP pathway, with a comprehensive discussion of pathophysiology, progression, and drug resistance.</div></div>","PeriodicalId":12673,"journal":{"name":"Gene Reports","volume":"40 ","pages":"Article 102272"},"PeriodicalIF":1.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452014425001451","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
One of the leading causes of cancer-related deaths globally is cervical cancer, which has many molecular mechanisms associated with its pathophysiology, including the dysfunction of the Hippo-YAP signalling system. The route can affect important biological processes such as cell growth, division, and survival. Risk factors for cervical cancer include long-term use of oral contraceptives, early sexual activity, multiple sexual partners, human papillomavirus infection, and cervical intraepithelial neoplasia. The disease mechanisms are regulated by many genes such as EGFR, MYC, CCND1, and ERBB2. The Hippo signalling pathway phosphorylates YAP/TAZ, thereby inhibiting carcinogenic potential. Dysregulation of the pathway has been linked with poor prognosis, lymph node metastasis, and cervical carcinoma in the early stage through YAP/TAZ activation. Progress in sequencing technologies, such as transcriptomics, single-cell genomic profiling, and multi-omics integration, has also shed light on this pathway for setting the foundation for better treatment. Vaccination against HPVs with high rates and intensive screening programs are critical for reducing cervical cancer incidence and death reduction. This review analyzed cervical cancer pathogenic genes and gene expression profiles by the Hippo-YAP pathway, with a comprehensive discussion of pathophysiology, progression, and drug resistance.
Gene ReportsBiochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.30
自引率
7.70%
发文量
246
审稿时长
49 days
期刊介绍:
Gene Reports publishes papers that focus on the regulation, expression, function and evolution of genes in all biological contexts, including all prokaryotic and eukaryotic organisms, as well as viruses. Gene Reports strives to be a very diverse journal and topics in all fields will be considered for publication. Although not limited to the following, some general topics include: DNA Organization, Replication & Evolution -Focus on genomic DNA (chromosomal organization, comparative genomics, DNA replication, DNA repair, mobile DNA, mitochondrial DNA, chloroplast DNA). Expression & Function - Focus on functional RNAs (microRNAs, tRNAs, rRNAs, mRNA splicing, alternative polyadenylation) Regulation - Focus on processes that mediate gene-read out (epigenetics, chromatin, histone code, transcription, translation, protein degradation). Cell Signaling - Focus on mechanisms that control information flow into the nucleus to control gene expression (kinase and phosphatase pathways controlled by extra-cellular ligands, Wnt, Notch, TGFbeta/BMPs, FGFs, IGFs etc.) Profiling of gene expression and genetic variation - Focus on high throughput approaches (e.g., DeepSeq, ChIP-Seq, Affymetrix microarrays, proteomics) that define gene regulatory circuitry, molecular pathways and protein/protein networks. Genetics - Focus on development in model organisms (e.g., mouse, frog, fruit fly, worm), human genetic variation, population genetics, as well as agricultural and veterinary genetics. Molecular Pathology & Regenerative Medicine - Focus on the deregulation of molecular processes in human diseases and mechanisms supporting regeneration of tissues through pluripotent or multipotent stem cells.